Literature DB >> 31683055

An update on genetic susceptibility in lupus nephritis.

Kangkang Song1, Lu Liu2, Xuejun Zhang3, Xiangmei Chen4.   

Abstract

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by multiple system involvement and positive serum autoantibodies. Lupus nephritis (LN) is the most common and serious complication of SLE, and it is the main cause of death in patients with SLE. Abnormalities in the immune system lead to LN and involve a variety of cells (T cells, B cells, macrophages, NK cells, etc.), cytokines (interleukin, tumor necrosis factor α, etc.) and their related pathways. Previous studies have shown that the interactions of genetic, epigenetic and environmental factors contribute to the pathogenesis and development of LN. In recent years, one genome-wide association study (GWAS) and a number of gene association studies have explored the susceptibility genes of LN, including immunization-, inflammation-, adhesion- and other pathway-related genes. These genes participate in or suggest the pathogenesis and progression of LN. In this review, we summarize the genetic susceptibility of LN and discuss the possible mechanism underlying the susceptibility genes of LN.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  Genetics; Lupus nephritis; Susceptibility; Systemic lupus erythematosus

Mesh:

Year:  2019        PMID: 31683055     DOI: 10.1016/j.clim.2019.108272

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  9 in total

Review 1.  IL-23/IL-17 Axis in Inflammatory Rheumatic Diseases.

Authors:  Hao Li; George C Tsokos
Journal:  Clin Rev Allergy Immunol       Date:  2020-11-13       Impact factor: 8.667

2.  Lupus Susceptibility Loci Predispose Mice to Clonal Lymphocytic Responses and Myeloid Expansion.

Authors:  Elliot H Akama-Garren; Michael C Carroll
Journal:  J Immunol       Date:  2022-04-27       Impact factor: 5.426

3.  The Impacts of the Clinical and Genetic Factors on Chronic Damage in Caucasian Systemic Lupus Erythematosus Patients.

Authors:  Fulvia Ceccarelli; Giulio Olivieri; Carmelo Pirone; Cinzia Ciccacci; Licia Picciariello; Francesco Natalucci; Carlo Perricone; Francesca Romana Spinelli; Cristiano Alessandri; Paola Borgiani; Fabrizio Conti
Journal:  J Clin Med       Date:  2022-06-12       Impact factor: 4.964

Review 4.  B Cell Aberrance in Lupus: the Ringleader and the Solution.

Authors:  YuXue Nie; Lidan Zhao; Xuan Zhang
Journal:  Clin Rev Allergy Immunol       Date:  2021-02-03       Impact factor: 8.667

5.  Interleukin-12 exacerbates symptoms in an MRL/MpJ-Faslpr mouse model of systemic lupus erythematosus.

Authors:  Ling Li; Xiaojun Sun; Sisi Wu; Xin Yuan; Bingxin Liu; Xueping Zhou
Journal:  Exp Ther Med       Date:  2021-04-15       Impact factor: 2.447

Review 6.  The Role of Immunometabolism in the Pathogenesis of Systemic Lupus Erythematosus.

Authors:  George Anthony Robinson; Meredyth G Ll Wilkinson; Chris Wincup
Journal:  Front Immunol       Date:  2022-01-26       Impact factor: 7.561

Review 7.  T Cells in Systemic Lupus Erythematosus.

Authors:  Jacqueline L Paredes; Ruth Fernandez-Ruiz; Timothy B Niewold
Journal:  Rheum Dis Clin North Am       Date:  2021-06-16       Impact factor: 2.032

8.  Alport syndrome combined with lupus nephritis in a Chinese family: A case report.

Authors:  Hui-Fang Liu; Qing Li; You-Qun Peng
Journal:  World J Clin Cases       Date:  2021-06-26       Impact factor: 1.337

Review 9.  Pathological mechanisms of abnormal iron metabolism and mitochondrial dysfunction in systemic lupus erythematosus.

Authors:  Chris Wincup; Natalie Sawford; Anisur Rahman
Journal:  Expert Rev Clin Immunol       Date:  2021-07-30       Impact factor: 4.473

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.